Overlapping GST proceedings require Central and State authorities to designate one competent authority for coordinated adjudication of the same matter...
Composite healthcare supplies retain exemption when patient care is the contract's essential character, despite payment through an implementing agency...
Receipt of immovable property requires actual possession or enjoyment; redevelopment allotments exchanged for tenancy rights fall outside deemed incom...
SC rejected the petition challenging the show cause notice under Section 124 of the Customs Act, 1962 regarding pharmaceutical raw materials export. The Court directed the DGFT to review the petitioner's representations and make an appropriate determination. The authority was instructed to proceed with adjudication after DGFT's decision. The court found the show cause notice process appeared procedurally valid, with no substantive response provided by the petitioner. The petition was disposed of, effectively allowing administrative reconsideration of the classification and export documentation.
SC rejected the petition challenging the show cause notice under Section 124 of the Customs Act, 1962 regarding pharmaceutical raw materials export. The Court directed the DGFT to review the petitioner's representations and make an appropriate determination. The authority was instructed to proceed with adjudication after DGFT's decision. The court found the show cause notice process appeared procedurally valid, with no substantive response provided by the petitioner. The petition was disposed of, effectively allowing administrative reconsideration of the classification and export documentation.
Note: It is a system-generated summary and is for quick reference only.